These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23058041)
1. Intestinal transporters for endogenic and pharmaceutical organic anions: the challenges of deriving in-vitro kinetic parameters for the prediction of clinically relevant drug-drug interactions. Grandvuinet AS; Vestergaard HT; Rapin N; Steffansen B J Pharm Pharmacol; 2012 Nov; 64(11):1523-48. PubMed ID: 23058041 [TBL] [Abstract][Full Text] [Related]
2. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates. Perri D; Ito S; Rowsell V; Shear NH Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033 [TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation. Bi YA; Kimoto E; Sevidal S; Jones HM; Barton HA; Kempshall S; Whalen KM; Zhang H; Ji C; Fenner KS; El-Kattan AF; Lai Y Drug Metab Dispos; 2012 Jun; 40(6):1085-92. PubMed ID: 22381335 [TBL] [Abstract][Full Text] [Related]
4. Transporter-mediated drug--drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Yoshida K; Maeda K; Sugiyama Y Clin Pharmacol Ther; 2012 Jun; 91(6):1053-64. PubMed ID: 22534868 [TBL] [Abstract][Full Text] [Related]
6. The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions. Polli JW; Humphreys JE; Harmon KA; Castellino S; O'Mara MJ; Olson KL; John-Williams LS; Koch KM; Serabjit-Singh CJ Drug Metab Dispos; 2008 Apr; 36(4):695-701. PubMed ID: 18216274 [TBL] [Abstract][Full Text] [Related]
7. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Fenner KS; Jones HM; Ullah M; Kempshall S; Dickins M; Lai Y; Morgan P; Barton HA Xenobiotica; 2012 Jan; 42(1):28-45. PubMed ID: 22077101 [TBL] [Abstract][Full Text] [Related]
8. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845 [TBL] [Abstract][Full Text] [Related]
9. Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings. Yu J; Zhou Z; Tay-Sontheimer J; Levy RH; Ragueneau-Majlessi I J Pharm Sci; 2017 Sep; 106(9):2312-2325. PubMed ID: 28414144 [TBL] [Abstract][Full Text] [Related]
10. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion. Robertson EE; Rankin GO Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085 [TBL] [Abstract][Full Text] [Related]
11. pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions. Kis O; Zastre JA; Ramaswamy M; Bendayan R J Pharmacol Exp Ther; 2010 Sep; 334(3):1009-22. PubMed ID: 20507927 [TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical excipients influence the function of human uptake transporting proteins. Engel A; Oswald S; Siegmund W; Keiser M Mol Pharm; 2012 Sep; 9(9):2577-81. PubMed ID: 22808947 [TBL] [Abstract][Full Text] [Related]
14. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. Kovacsics D; Patik I; Özvegy-Laczka C Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):409-424. PubMed ID: 27783531 [TBL] [Abstract][Full Text] [Related]
15. Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption. Harwood MD; Neuhoff S; Carlson GL; Warhurst G; Rostami-Hodjegan A Biopharm Drug Dispos; 2013 Jan; 34(1):2-28. PubMed ID: 22927116 [TBL] [Abstract][Full Text] [Related]
17. Transporter-Mediated Drug-Drug Interactions and Their Significance. Liu X Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Shitara Y; Sato H; Sugiyama Y Annu Rev Pharmacol Toxicol; 2005; 45():689-723. PubMed ID: 15822193 [TBL] [Abstract][Full Text] [Related]
19. Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Nies AT; Schwab M; Keppler D Expert Opin Drug Metab Toxicol; 2008 May; 4(5):545-68. PubMed ID: 18484914 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy. Burckhardt G; Burckhardt BC Handb Exp Pharmacol; 2011; (201):29-104. PubMed ID: 21103968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]